TEM:NASDAQTempus AI, Inc. Analysis
Data as of 2026-09-13 - not real-time
$59.01
Latest Price
9/10Risk
Risk Level: High
Executive Summary
At $59.01, Tempus AI, Inc. shows no decisive moving-average alignment, leaving the trend neutral. Across the trailing 30 sessions it gained 33.2%. With RSI at 48.3 the momentum picture is neutral, alongside a bearish MACD signal. Watch $49.35 as support and $72.96 as the nearer resistance level.
The shares look overvalued, trading on 14752.5 times earnings above a sector average of 29.5. Consensus targets land 15.5% above where the shares trade now. Revenue is growing at 21.6% on a -17.8% profit margin.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 98.3%, a beta of 2.53 and a maximum drawdown of 59.8%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
This one splits by horizon — hold in the near term, sell further out, at 6/10 long-term conviction.
The shares look overvalued, trading on 14752.5 times earnings above a sector average of 29.5. Consensus targets land 15.5% above where the shares trade now. Revenue is growing at 21.6% on a -17.8% profit margin.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 98.3%, a beta of 2.53 and a maximum drawdown of 59.8%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
This one splits by horizon — hold in the near term, sell further out, at 6/10 long-term conviction.
Top Market Events
Tempus AI Inc. TEM stock is surging over 11% on Friday at the time of publication. The price movement is primarily...Personalis holders receive Tempus shares worth $16.Seeking Alpha26dTempus AI: The Data Flywheel Has Started SpinningTempus AI reported its first GAAP profit, accelerated...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 3/10
Key Factors
- Trading above the 200-day average of 56.27
- MACD momentum is negative
- 30-day price change of +33.2%
Medium Term
1–3 yearsCautious
Model confidence: 4/10
Key Factors
- P/E of 14752.5 versus sector average of 29.5
- Trading above the 200-day average of 56.27
- Analyst targets imply +15.5% versus the current price
Long Term
> 3 yearsCautious
Model confidence: 6/10
Key Factors
- P/E of 14752.5 versus sector average of 29.5
- Negative profit margin of -17.8%
- Analyst targets imply +15.5% versus the current price
Key Metrics & Analysis
Financial Health
Revenue Growth21.60%
Profit Margin-17.77%
P/E Ratio14752.5
ROE-67.44%
ROA-8.55%
Debt/Equity324.58
P/B Ratio23.9
Op. Cash Flow$-237432000
Free Cash Flow$-93493376
Industry P/E29.5
Technical Analysis
TrendNeutral
RSI48.3
Support$49.35
Resistance$72.96
MA 20$62.58
MA 50$55.88
MA 200$56.27
MACDBearish
VolumeDecreasing
Fear & Greed Index93.14
Valuation
Target Price$68.18
Upside/Downside15.53%
GradeOvervalued
TypeGrowth
Risk Assessment
Beta2.53
Volatility98.32%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.